Chemotherapy in Non-Small Cell Lung Cancer
- 1 May 2000
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 18 (2) , 157-186
- https://doi.org/10.1023/a:1006330030333
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)Lung Cancer, 1998
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the italian oncology group for clinical researchLung Cancer, 1995
- Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerCancer, 1995
- A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1994
- Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- The Current and Future Place of Vinorelbine in Cancer TherapyDrugs, 1992
- Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)Cancer, 1982
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982